documents: FDA-1996-D-0048-0006
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1996-D-0048-0006 | FDA | FDA-1996-D-0048 | Guidance for Industry Q3B(R2) Impurities in New Drug Products | Other | Guidance | 2021-10-27T04:00:00Z | 2021 | 10 | 2021-10-27T04:00:00Z | 2021-10-27T16:06:56Z | 0 | 0 | 0900006484dfa462 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref